Clinical trials recruiting for Stage IIB Breast Cancer
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Anastrozole | 1 |
| Anastrozole 1mg | 1 |
| Chemoradiation | 1 |
| Elacestrant | 1 |
| Exemestane 25 MG | 1 |
| Letrozole 2.5mg | 1 |
| Tamoxifen | 1 |
| Trastuzumab deruxtecan | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 1 |
| Florida | 1 |
| Indiana | 1 |
| Kansas | 1 |
| Massachusetts | 1 |
Top cities
Self-screener
Recruiting trials
- Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)
- Postoperative Radiotherapy in Breast Cancer- Concurrent or Sequential With Chemotherapy
- Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer
Related conditions
Trials recruiting for Stage IIB Breast Cancer often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Stage IIB Breast Cancer trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.